Maja B. Juul
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Journal: Blood cancer journal
Published: May 14, 2024
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Journal: Hematological oncology
Published: November 03, 2019
No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients.
Journal: Leukemia & lymphoma
Published: May 07, 2019
Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas.
Journal: Leukemia & lymphoma
Published: November 15, 2018
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Journal: British journal of haematology
Published: May 28, 2018
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 23, 2017
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 18, 2017
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 30, 2016
Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.
Journal: British journal of haematology
Published: April 26, 2016
Last Updated: 09/26/2026